IRWD- Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. (IRWD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.84M | - | |
| Dir | 676.9K | $2.80M | - | |
| VP | 658.0K | $2.72M | - | |
| Other | 500.5K | $2.07M | - | |
| Other | 416.6K | $1.72M | - |
Activity
Buys and sells only
Transactions
10 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 27,000 | $12.39 | $334,530.00 | -7.2% | -13.5% | -7.7% | |
| Nov 21, 2022 | Emany Sravan Kumar47 | SVP, Chief Financial Officer | Sell | 6,578 | $11.56 | $76,041.68 | -7.7% | +1.7% | -18.2% | |
| Nov 21, 2022 | Silver Ronald68 | Principal Accounting Officer | Sell | 682 | $11.56 | $7,883.92 | -0.6% | +1.7% | -18.2% | |
| Nov 21, 2022 | Davis Andrew73 | SVP, Chief Business Officer | Sell | 3,335 | $11.56 | $38,552.60 | -2.1% | +1.7% | -18.2% | |
| Oct 3, 2022 | McCourt Thomas A66 | Chief Executive Officer | Sell | 18,899 | $10.41 | $196,738.59 | -2.6% | +18.3% | -6.5% | |
| Sep 1, 2022 | McCourt Thomas A66 | Chief Executive Officer | Sell | 26,446 | $10.65 | $281,649.90 | -3.5% | +11.8% | -14.5% | |
| Aug 15, 2022 | Silver Ronald68 | Principal Accounting Officer | Sell | 2,014 | $11.77 | $23,704.78 | -1.9% | -3.8% | -17.2% | |
| Aug 15, 2022 | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 994 | $11.77 | $11,699.38 | -0.3% | -3.8% | -17.2% | |
| Aug 15, 2022 | John Minardo69 | Chief Legal Officer | Sell | 7,330 | $11.77 | $86,274.10 | -5.0% | -3.8% | -17.2% | |
| Aug 11, 2022 | Currie Mark G53 | Director | Sell | 70,000 | $11.78 | $824,600.00 | -11.8% | -1.4% | -12.8% |